Acquisition method (AMC)
1
FSC 6505 × PHENAZOPYRIDINE HYDROCHLORIDE TA
PHENAZOPYRIDINE HYDROCHLORIDE TA
6505-00-138-8461 FSC 6505
NSN 6505-00-138-8461 (also written 6505001388461; NIIN 00-138-8461) is a phenazopyridine hydrochloride ta in Federal Supply Class 6505, Drugs and Biologicals. 9 manufacturer part numbers from 7 suppliers are on record. It was last purchased in Sep 2026.
Open for bid
No open solicitations on record for this NSN right now.
Can you win it?
This item is coded as suitable for competitive acquisition (AMC 1).
Suffix (AMSC)
Z
Competition
Coded for competition
AMC 1: suitable for competitive acquisition, second or later time. AMSC Z: a commercial, nondevelopmental or off-the-shelf item. The codes describe the item's status on record, not any one solicitation. What the codes mean
What it is — can you make it?
Dimensions, the FLIS specification requirements, and the manufacturer part numbers already qualified against this NSN.
Specifications
From the federal catalog (DLA FLIS / PUB LOG) — what your part has to meet. Cited specification documents can be looked up in ASSIST Quick Search ↗, DoD's public spec repository — copy the document number in.
| Requirement | Value |
|---|---|
| MEDICAL DESIGNATION AND GRADE MDES | UNITED STATES PHARMACOPEIA |
| SPECIAL FEATURES FEAT | STORE AT USP CONTROLLED ROOM TEMPERATURE 20 TO 25 C (68 TO 77 F) EXCURSIONS PERMITTED TO 15 TO 30 C (59 TO 86 F) SEE USP CONTROLLED ROOM TEMPERATURE. |
| SUPPLEMENTARY FEATURES SUPP | D-DAY ITEM FOR DOD |
| PART NAME ASSIGNED BY CONTROLLING AGENCY CXCY | PHENAZOPYRIDINE HYDROCHLORIDE TABLETS USP 100 MG 100 TABLETS BT |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH AKJA | MILLIGRAMS PHENAZOPYRIDINE HYDROCHLORIDE ACTIVE INGREDIENT 100.000 |
| PRIMARY CONTAINER CONTENT QUANTITY CRLK | TABLETS 100.000 |
| PRIMARY CONTAINER TYPE CQCT | BOTTLE |
Manufacturer part numbers
Commercial part numbers cross-referenced to this NSN in the federal catalog — the parts that have been accepted as satisfying this stock number, and who makes them.
| Part number | CAGE | Manufacturer |
|---|---|---|
| NDC42937-0701-10 | 61RJ6 | UNITED DRUG SUPPLY INC DBA UNITED DRUG SUPPLY INC |
| NDC42937-0701-10 | 660P4 | BI COASTAL PHARMACEUTICAL |
| NDC51293-0810-01 | 7AMD3 | ECI PHARMACEUTICALS LLC DBA ECI PHARMACEUTICALS |
| NDC58657-0450-01 | 74XY7 | METHOD PHARMACEUTICALS, LLC DBA METHOD PHARMACEUTICALS LLC DIV METHOD PHARMACEUTICALS |
| NDC60846-0501-01 | 7AN71 | GEMINI LABORATORIES LLC |
| NDC65162-0681-10 | 557X3 | AMNEAL PHARMACEUTICALS OF NEW YORK, LLC |
| NDC75826-0114-10 | 00E55 | CARDINAL HEALTH, INC. |
| PYRIDIUM | 7AN71 | GEMINI LABORATORIES LLC |
| PYRIDIUM 100MG 100S | 7AN71 | GEMINI LABORATORIES LLC |
What it pays — so you can quote
The government's own price and demand record for this NSN — what past awards cleared at, so you know where to land your quote.
Latest unit price
—
Purchases
0
Total spend
—
Sep 29, 2026
Last purchased
5 · 5.0/yr
Purchase records
$2,714
Total demand
$452.30
Latest award total
Purchase history
No priced purchases on record for this NSN yet.
Related contract actions
Contract action totals, not unit prices — obligation amounts from USAspending for related awards, shown for context only. These do not appear on the price chart above.
| Action date | Award # | Recipient | Agency | Obligation |
|---|---|---|---|---|
| Sep 22, 2026 | SPE2DX25D9900/SPE2DP26F006D ↗ | DMS PHARMACEUTICAL GROUP INC | — | $904.60 |
| Sep 25, 2026 | SPE2DX25D9900/SPE2DP26F018P ↗ | DMS PHARMACEUTICAL GROUP INC | — | $452.30 |
| Sep 28, 2026 | SPE2DX25D9900/SPE2DP26F019U ↗ | DMS PHARMACEUTICAL GROUP INC | — | $452.30 |
| Sep 28, 2026 | SPE2DX25D9900/SPE2DP26F020P ↗ | DMS PHARMACEUTICAL GROUP INC | — | $452.30 |
| Sep 29, 2026 | SPE2DX25D9900/SPE2DP26F028M ↗ | DMS PHARMACEUTICAL GROUP INC | — | $452.30 |
Demand history
Who wins this item
Does one supplier win this every time, and are the winners on the listed-source list? One dot per award.
- Award in the last 2 years
- Older award
DMS PHARMACEUTICAL GROUP INC
last award Sep 2026
AMNEAL PHARMACEUTICALS OF NEW YORK, LLC
no award yet
no awards on record
Listed source BI COASTAL PHARMACEUTICAL
no award yet
no awards on record
Listed source CARDINAL HEALTH, INC.
no award yet
no awards on record
Listed source ECI PHARMACEUTICALS LLC DBA ECI PHARMACEUTICALS
no award yet
no awards on record
Listed source GEMINI LABORATORIES LLC
no award yet
no awards on record
Listed source METHOD PHARMACEUTICALS, LLC DBA METHOD PHARMACEUTICALS LLC DIV METHOD PHARMACEUTICALS
no award yet
no awards on record
Listed source UNITED DRUG SUPPLY INC DBA UNITED DRUG SUPPLY INC
no award yet
no awards on record
Listed source DMS PHARMACEUTICAL GROUP INC won 5 of the last 5 awards. DMS PHARMACEUTICAL GROUP INC won without being a listed source.
Open RFQs on DIBBS → DIBBS award history ↗
About this data
- Unit prices: DLA DIBBS award records — every row links to its government record.
- AMSC: latest observed value from DIBBS solicitation history as of Oct 10, 2026.
- Contract action totals: USAspending, context only.
- Data last refreshed: 2026-09-30.
- Full methodology →
Cite this page
Citation
NSN Explorer. "PHENAZOPYRIDINE HYDROCHLORIDE TA." nsnexplorer.com, https://nsnexplorer.com/nsn/6505-00-138-8461/. Data as of October 19, 2026.
Link
https://nsnexplorer.com/nsn/6505-00-138-8461/